Suppr超能文献

[非心脏外科手术围手术期心血管发病率和死亡率:优化麻醉护理的措施]

[Perioperative cardiovasular morbidity and mortality in noncardiac surgical interventions : Measures for optimal anesthesiological care].

作者信息

Janßen H, Dehne S, Giannitsis E, Weigand M A, Larmann J

机构信息

Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland.

Klinik für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland.

出版信息

Anaesthesist. 2019 Oct;68(10):653-664. doi: 10.1007/s00101-019-0616-9.

Abstract

Because of new surgical techniques, advanced monitoring modalities and improvements in perioperative care, perioperative mortality and morbidity have been significantly reduced in the last decades; however, patients still suffer from high perioperative mortality and morbidity, especially those with pre-existing cardiovascular diseases. Not only perioperative myocardial infarction but also myocardial injury after non-cardiac surgery, which presents without clinical symptoms, is associated with an adverse outcome. Patients at risk require particular interdisciplinary attention throughout the perioperative phase. The premedication visit is of particular importance. In addition to a thorough patient medical history and physical assessment, the perioperative handling of the patient's pre-existing medication and possible necessity for further preoperative tests should be verified. If necessary and where possible, optimization of the patient's state of health can be planned together with other disciplines. It is the anesthesiologist's responsibility to optimally guide and support patients with pre-existing cardiovascular diseases through the entire surgical procedure. This review summarizes perioperative interventions that have an influence on patient mortality and morbidity and evaluates the underlying evidence. This covers the perioperative handling of cardioprotective medication, choice of the anesthetic regimen, blood pressure management and transfusion regimens. Furthermore, this review highlights recent findings, e.g. perioperative reloading with statins and short-term preoperative initiation of beta blockers. The pros and cons of thoracic epidural anesthesia in patients with an elevated cardiovascular risk are discussed. Not only intraoperative hypotension should be of concern to anesthesiologists but also postoperative hypotension can have a deleterious impact on the outcome. This is relevant in the time period when a significant proportion of patients have already left the monitoring ward. The recently published recommendations by the World Health Organization concerning perioperative hyperoxia might not be beneficial for patients with an elevated cardiovascular risk. Finally, the treatment options for perioperative cardiovascular events are explained and an algorithm for handling of patients with perioperative myocardial injury without clinical ischemic symptoms is suggested (myocardial injury after non-cardiac surgery).

摘要

由于新的外科技术、先进的监测方式以及围手术期护理的改善,在过去几十年中围手术期死亡率和发病率已显著降低;然而,患者仍面临较高的围手术期死亡率和发病率,尤其是那些患有心血管疾病的患者。不仅围手术期心肌梗死,非心脏手术后无临床症状的心肌损伤也与不良预后相关。高危患者在整个围手术期需要特别的多学科关注。术前访视尤为重要。除了全面的患者病史和体格检查外,还应核实患者现有药物的围手术期处理以及进一步术前检查的可能必要性。如有必要且可行,可与其他学科共同规划患者健康状况的优化。麻醉医生有责任在整个手术过程中为患有心血管疾病的患者提供最佳的指导和支持。本综述总结了对患者死亡率和发病率有影响的围手术期干预措施,并评估了相关证据。这涵盖了心脏保护药物的围手术期处理、麻醉方案的选择、血压管理和输血方案。此外,本综述强调了近期的研究结果,例如围手术期补充他汀类药物以及术前短期启动β受体阻滞剂。讨论了心血管风险升高患者采用胸段硬膜外麻醉的利弊。麻醉医生不仅应关注术中低血压,术后低血压也可能对预后产生有害影响。这在很大一部分患者已经离开监测病房的时间段内具有相关性。世界卫生组织最近发布的关于围手术期高氧的建议可能对心血管风险升高的患者并无益处。最后,解释了围手术期心血管事件的治疗选择,并提出了一种处理无临床缺血症状的围手术期心肌损伤患者(非心脏手术后心肌损伤)的算法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验